Search International and National Patent Collections

1. (WO2018221521) ANTI-IGF-I RECEPTOR ANTIBODY

Pub. No.:    WO/2018/221521    International Application No.:    PCT/JP2018/020581
Publication Date: Fri Dec 07 00:59:59 CET 2018 International Filing Date: Wed May 30 01:59:59 CEST 2018
IPC: C07K 16/28
A01K 67/027
A61K 35/12
A61K 35/34
A61K 35/76
A61K 39/395
A61K 45/00
A61K 48/00
A61P 1/04
A61P 1/12
A61P 1/16
A61P 1/18
A61P 3/00
A61P 3/04
A61P 3/10
A61P 9/00
A61P 9/10
A61P 9/14
A61P 11/00
A61P 13/08
A61P 13/10
A61P 13/12
A61P 15/00
A61P 17/02
A61P 17/06
A61P 19/08
A61P 19/10
A61P 21/02
A61P 21/04
A61P 25/00
A61P 27/02
A61P 27/16
A61P 35/00
A61P 35/02
A61P 37/06
C12N 1/15
C12N 1/19
C12N 1/21
C12N 5/10
C12N 15/13
C12N 15/63
C12P 21/08
Applicants: TEIJIN PHARMA LIMITED
帝人ファーマ株式会社
Inventors: EGUCHI, Hiroshi
江口 広志
TANOKURA, Akira
田野倉 章
TAKAGI, Kenichiro
高木 健一郎
KATO, Hirotsugu
加藤 浩嗣
YAMAMURA, Satoshi
山村 聡
NAMIKI, Naoko
並木 直子
Title: ANTI-IGF-I RECEPTOR ANTIBODY
Abstract:
The present invention provides an anti-IGF-I receptor antibody that binds specifically to an IGF-I receptor of a vertebrate and has the proliferation-inducing activity of a vertebrate-derived cell, or a fragment thereof, or derivatives of these.